01/08/2020
2:11 PM | Loxo Oncology (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/25/2019
10:28 AM | Loxo Oncology (Filer)
| Form 15-12B
| |
02/21/2019
11:15 PM | Loxo Oncology (Filer)
| Form EFFECT
| |
02/15/2019
3:55 PM | Loxo Oncology (Filer)
| Form S-8 POS
| |
02/15/2019
3:51 PM | Loxo Oncology (Filer)
| Form S-8 POS
| |
02/15/2019
3:49 PM | Loxo Oncology (Filer)
| Form S-8 POS
| |
02/15/2019
3:47 PM | Loxo Oncology (Filer)
| Form S-8 POS
| |
02/15/2019
3:46 PM | Loxo Oncology (Filer)
| Form S-8 POS
| |
02/15/2019
3:41 PM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2019
3:39 PM | Loxo Oncology (Filer)
| Form POSASR
| |
|
02/15/2019
3:36 PM | Loxo Oncology (Filer)
| Form POS AM
| |
02/15/2019
3:05 PM | AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
| Form SC 13D/A
| |
02/15/2019
8:23 AM | Loxo Oncology (Subject)
| Form SC 14D9/A
| |
02/15/2019
8:20 AM | LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
| Form SC TO-T/A
| |
02/15/2019
8:18 AM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:17 AM | Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:16 AM | Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:15 AM | Loxo Oncology (Subject)
The Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE
| |
02/15/2019
8:14 AM | Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:14 AM | Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:13 AM | Harr Steve (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:12 AM | Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:11 AM | Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:09 AM | ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:07 AM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
8:06 AM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
12:51 PM | Loxo Oncology (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
02/13/2019
1:08 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Loxo Oncology (Subject)
| Form SC 13G/A
| |
02/12/2019
8:58 AM | Loxo Oncology (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/11/2019
12:59 PM | Loxo Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/11/2019
8:14 AM | FMR LLC (Filed by)
Loxo Oncology (Subject)
| Form SC 13G/A
| |
02/08/2019
11:33 AM | FMR LLC (Filed by)
Loxo Oncology (Subject)
| Form SC 13G/A
| |
02/06/2019
2:03 PM | BlackRock Inc. (Filed by)
Loxo Oncology (Subject)
| Form SC 13G/A
| |
02/05/2019
3:00 PM | Loxo Oncology (Subject)
| Form SC 14D9/A
| |
02/01/2019
6:18 AM | Loxo Oncology (Subject)
| Form SC 14D9/A
| |
02/01/2019
6:16 AM | LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
| Form SC TO-T/A
| |
01/17/2019
7:08 AM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4/A
| |
01/17/2019
7:06 AM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4/A
| |
01/17/2019
6:37 AM | Loxo Oncology (Subject)
| Form SC 14D9
| |
01/17/2019
6:35 AM | LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
| Form SC TO-T
| |
01/15/2019
3:08 PM | LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
| Form SC 13D
| |
01/15/2019
7:30 AM | AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
| Form SC 13D/A
| |
01/10/2019
2:25 PM | Loxo Oncology (Subject)
SANDS CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
01/08/2019
4:08 PM | LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
| Form SC TO-C
| |
01/07/2019
4:09 PM | Loxo Oncology (Subject)
| Form SC14D9C
| |
01/07/2019
1:59 PM | LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
| Form SC TO-C
| |
01/07/2019
6:14 AM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2019
4:08 PM | Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:06 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:04 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:03 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:02 PM | Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
3:30 PM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
4:07 PM | Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
4:17 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
4:14 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
4:12 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
3:30 PM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2018
4:13 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2018
4:09 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2018
4:08 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
5:01 AM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2018
3:31 PM | Loxo Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2018
5:45 AM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2018
3:46 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
3:44 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
3:42 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2018
5:45 AM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2018
5:19 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2018
5:17 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2018
5:14 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2018
4:27 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2018
4:25 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2018
4:23 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2018
3:39 PM | Loxo Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/09/2018
3:03 PM | Loxo Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2018
5:46 AM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2018
3:45 PM | AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
| Form SC 13D/A
| |
07/12/2018
3:45 PM | AISLING CAPITAL III LP (Reporting)
Aisling Capital Partners III LLC (Reporting)
Aisling Capital Partners III LP (Reporting)
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Purcell Dennis J (Reporting)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2018
4:04 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2018
4:03 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2018
4:01 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2018
9:52 AM | FMR LLC (Filed by)
Loxo Oncology (Subject)
| Form SC 13G/A
| |
06/21/2018
4:04 PM | Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
4:03 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
4:02 PM | Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
4:00 PM | Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:10 PM | Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:07 PM | Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:05 PM | Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:04 PM | Harr Steve (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:03 PM | Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:02 PM | Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:01 PM | ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
4:00 PM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2018
5:02 PM | Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
5:01 PM | Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
5:00 PM | Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2018
5:46 AM | Loxo Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2018
3:46 PM | Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
